Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment by Sahar Eljack, Stephanie David, Igor Chourpa, Areeg Faggad, Emilie Allard-Vannier

Connect to this object online.

Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal by Sahar Eljack, Stephanie David, Areeg Faggad, Igor Chourpa, Emilie Allard-Vannier

Connect to this object online.

In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model by Phuoc Vinh Nguyen, Katel Hervé-Aubert, Laurie Lajoie, Yoann Misericordia, Igor Chourpa, Stéphanie David, Emilie Allard-Vannier

Connect to this object online.

Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells by Sahar Eljack, Emilie Allard-Vannier, Yoann Misericordia, Katel Hervé-Aubert, Nicolas Aubrey, Igor Chourpa, Areeg Faggad, Stephanie David

Connect to this object online.

DNA Nanocarriers for Systemic Administration: Characterization and In Vivo Bioimaging in Healthy Mice by Stephanie David, Catherine Passirani, Nathalie Carmoy, Marie Morille, Mathieu Mevel, Benoit Chatin, Jean-Pierre Benoit, Tristan Montier, Bruno Pitard

Connect to this object online.